All In Biotech

Drug Trial Radar · NCT03453528

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors

Last checked: Nov 19, 2026Latest source record: Jan 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,225

Actual

Start

Jul 4, 2017

Primary completion

Dec 4, 2024

Study completion Jan 3, 2025

Sponsor

Sponsor type
Academic, hospital or other
First posted
Mar 5, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

multi-centre, prospective, diagnostic trial to evaluate the Prostate-Specific Membrane Antigen (PSMA-antigen) over-expression in metastatic castration resistant prostate cancer (mCRPC) and in advanced/metastatic solid tumors patients.

Conditions

  • Prostate-specific Membrane Antigen
  • mCRPC or Advanced/Metastatic Solid Tumors

Interventions

  • 68Ga-PSMADrug

    68Ga-PSMA will be injected intravenously via an indwelling catheter in an antecubital vein; (68Ga-PSMA activity: min 100 MBq - max 200 MBq, weighted activity: 2.0 MBq/Kg).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. detection rate of 68Ga-PSMA PET/CTTime frame: up to 36 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)

    Meldola, FC, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.